probenecid

E850001

Probenecid is a uricosuric medication primarily used to treat gout and hyperuricemia and to modify the renal excretion of various drugs.

All labels observed (1)

Label Occurrences
probenecid canonical 1

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf gout medication ⓘ
organic acid ⓘ
pharmaceutical drug ⓘ
small molecule ⓘ
uricosuric agent ⓘ
actsOnTarget OAT1 transporter ⓘ
OAT3 transporter ⓘ
URAT1 transporter ⓘ
hasATCCode M04AB01 ⓘ
hasBioavailability high oral bioavailability ⓘ
hasCASNumber 57-66-9 ⓘ
hasChemicalFormula C13H19NO4S ⓘ
hasDrugInteractionWith NSAIDs ⓘ
aspirin ⓘ
methotrexate ⓘ
salicylates ⓘ
hasEliminationHalfLife approximately 4 to 12 hours ⓘ
hasIUPACName 4-[(dipropylsulfamoyl)methyl]benzoic acid ⓘ
hasMechanismOfAction inhibits organic anion transporters in renal proximal tubules ⓘ
inhibits renal tubular reabsorption of uric acid ⓘ
hasMolarMass 285.36 g/mol ⓘ
hasPregnancyCategory varies by jurisdiction ⓘ
hasRouteOfAdministration oral ⓘ
hasTherapeuticUse adjunct to antibiotic therapy ⓘ
prevention of gouty arthritis attacks ⓘ
treatment of gout ⓘ
treatment of hyperuricemia ⓘ
increasesRenalExcretionOf uric acid ⓘ
increasesSerumConcentrationOf penicillin ⓘ
isAdministeredAs oral tablet ⓘ
isContraindicatedIn acute gout attack ⓘ
severe renal impairment ⓘ
uric acid kidney stones ⓘ
isExcretedBy kidney ⓘ
isIndicatedFor chronic gout ⓘ
hyperuricemia associated with gout ⓘ
isListedOn World Health Organization Model List of Essential Medicines ⓘ
isMetabolizedBy liver ⓘ
isProteinBound high protein binding ⓘ
mayCauseAdverseEffect gastrointestinal upset ⓘ
headache ⓘ
kidney stones ⓘ
rash ⓘ
modifiesPharmacokineticsOf cephalosporins ⓘ
penicillin ⓘ
linked to: penicillins

some antiviral drugs ⓘ
wasFirstApprovedIn 1951 ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

methotrexate → interactsWith → probenecid ⓘ